Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Inhaled nitric oxide in patients with acute respiratory distress syndrome caused by COVID-19: treatment modalities, clinical response, and outcomes

Abstract Background Inhaled nitric oxide (iNO) has been widely used in patients with COVID-19-related acute respiratory distress syndrome (C-ARDS), though its physiological effects and outcome are debated in this setting. The objective of this cohort study was to describe the modalities of iNO use,...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron: Armand Mekontso Dessap, Laurent Papazian, Manuella Schaller, Saad Nseir, Bruno Megarbane, Luc Haudebourg, Jean-François Timsit, Jean-Louis Teboul, Khaldoun Kuteifan, Marc Gainnier, Michel Slama, Patrick Houeto, Laurent Lecourt, Alain Mercat, Antoine Vieillard-Baron
Fformat: Erthygl
Iaith:English
Cyhoeddwyd: SpringerOpen 2023-06-01
Cyfres:Annals of Intensive Care
Pynciau:
COVID-19
Acute respiratory distress syndrome
Inhaled nitric oxide
Refractory hypoxaemia
ECMO
Mynediad Ar-lein:https://doi.org/10.1186/s13613-023-01150-9

Rhyngrwyd

https://doi.org/10.1186/s13613-023-01150-9

Eitemau Tebyg